World Health Organization. Global tuberculosis report 2019. [cited 2021 May 24]: [283 p.]. Available from: Geneva: World Health Organization. 2020. Licence: CC BY-NC-SA 3.0 IGO.

Especial N. Secretaria de Vigilância em Saúde| Ministério da Saúde Boletim Epidemiológico. 2020.

Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372(22):2127–35.

Article  CAS  PubMed  Google Scholar 

Souto A, Maneiro JR, Salgado E, Carmona L, Gomez-Reino JJ. Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies. Rheumatology (Oxford). 2014;53(10):1872–85.

Article  CAS  PubMed  Google Scholar 

Yonekura CL, Oliveira RDR, Titton DC, Ranza R, Ranzolin A, Hayata AL, et al. Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological therapies in Rheumatic diseases (Registro Brasileiro De Monitoração De Terapias Biológicas– BiobadaBrasil). Revista Brasileira De Reumatologia (English Edition). 2017;57:477–83.

Article  Google Scholar 

Sartori NS, de Andrade NPB, da Silva Chakr RM. Incidence of tuberculosis in patients receiving anti-TNF therapy for rheumatic diseases: a systematic review. Clin Rheumatol. 2020;39:1439–47.

Article  PubMed  Google Scholar 

Gomes CMF, Terreri MT, de Moraes-Pinto MI, Barbosa C, Machado NP, Melo MR, et al. Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline - A longitudinal analysis after using TNFα blockers. Mem Inst Oswaldo Cruz. 2015;110(7):921–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomes CMF, Terreri MT, de Moraes-Pinto MI, Pinheiro MM. Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis on anti-TNFα inhibitors: a 24-month prospective study. Adv Rheumatol. 2021;61:71.

Article  PubMed  Google Scholar 

Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum. 2005;52(6):1766–72.

Article  CAS  PubMed  Google Scholar 

Mota L, Cruz B, Brenol C, Pereira I, Rezende-Fronza L, Bertolo M, et al. 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis. Rev Bras Reumatol. 2012;52:152–74.

Article  PubMed  Google Scholar 

Bonfiglioli KR, Ribeiro ACM, Moraes JCB, Saad CGS, Souza FHC, Calich AL, et al. LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area. Int J Tuberculosis Lung Disease. 2014;18(8):905–11.

Article  CAS  Google Scholar 

Getahun H, Matteelli A, Abubakar I, Abdel Aziz M, Baddeley A, Barreira D, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal. Volume 46. European Respiratory Society; 2015. pp. 1563–76.

American Thoracic Society Targeted Tuberculin Testing and Treatment of Latent. Am J Respi Crit Care Med. 1999;161(3):221–47. Available from: www.atsjournals.org.

Iannone F, Cantini F, Lapadula G, Iannone F, Cantini F, Lapadula G. Diagnosis of latent tuberculosis and Prevention of Reactivation in Rheumatic patients receiving biologic therapy: International recommendations diagnosis of latent tuberculosis and Prevention of Reactivation in Rheumatic. Patients Receiving Biologic Thera. 2014;91.

Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, et al. European League against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75(3):499–510.

Article  CAS  PubMed  Google Scholar 

Brunelli JB, Bonfiglioli KR, Silva CA, Kozu KT, Goldenstein-Schainberg C, Bonfa E, et al. Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a Tuberculosis high-risk country. Revista brasileira de reumatologia. 2017;57(5):392–6.

Article  PubMed  Google Scholar 

Chen DY, Shen GH, Hsieh TY, Hsieh CW, Lan JL. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum. 2008;59(6):800–6.

Fuchs I, Avnon L, Freud T, Abu-Shakra M. Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin Rheumatol. 2009;28(2):167–72.

Article  PubMed  Google Scholar 

Hatzara C, Hadziyannis E, Kandili A, Koutsianas C, Makris A, Georgiopoulos G, et al. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases. Ann Rheum Dis. 2015;74(10):1848–53.

Article  CAS  PubMed  Google Scholar 

Jeong HP, Ga YS, Jin SL, Kim TH, Yoo DH. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial. J Rheumatol. 2009;36(10):2158–63.

Article  Google Scholar 

Cuomo G, D’Abrosca V, Iacono D, Pantano I. The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis. Clin Rheumatol. 2017;36(2):457–61.

Article  PubMed  Google Scholar 

Yamamoto S, Nagatani K, Sato T, Iwamoto M, Takatori S, Minota S. Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis. Int J Rheum Dis. 2017;20(5):584–8.

Article  CAS  PubMed  Google Scholar 

Hejazi ME, Ahmadzadeh A, Khabbazi A, et al. Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents. BMC Infect Dis. 2020;20(1):464.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis and Rheumatism, vol 62. John Wiley and Sons Inc.; 2010. pp. 2569–81.

Arnett FC, Edworthy SM, Bloch DA, McSHANE DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 Revised Criteria for the classification of Rheumatoid Arthritis. 1988.

Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006.

Rudwaleit M, Van Der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83.

Article  CAS  PubMed  Google Scholar 

Reitblat O, Lerman TT, Cohen O, Reitblat T. The effect of prednisone on tuberculin skin test reaction in patients with rheumatoid arthritis. Int J Rheumatol. 2018;2018.

Mangini C, de Melo FAF. Artrite reumatoide, terapia imunossupressora e tuberculose. Rev Bras Reumatol. 2003;43(6):11–5.

Article  Google Scholar 

Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, et al. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev. 2015;14(6):503–9.

Article  PubMed  Google Scholar 

Inanc N, Aydin SZ, Karakurt S, Akagunduz P, Yavuz S, Direskeneli H. Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol. 2009;36(12):2675–81.

Article  PubMed  Google Scholar 

Murakami S, Takeno M, Kirino Y, Atagunduz P, Yavuz S, Direskeneli H. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis. Tuberculosis (Edinb). 2009;89(2):136–41.

Article  CAS  PubMed  Google Scholar 

Sargın G, Şentürk T, Ceylan E, Telli M, Çildağ S, Doğan H. TST, QuantiFERON-TB gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy. Tuberk Toraks. 2018;66(2):136–43.

Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, et al. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Arthritis Rheum. 2012;64(7):2068–77.

Article  CAS  PubMed  Google Scholar 

Kevin F et al. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005;1–47.

Chaer FGG, de Lucena Valim JM, Reis RC, Klautau GB, de Souza BDB. Use of biologic agents and risk of tuberculosis in Brazil, a Tuberculosis high-burden country. Drugs Context. 2020;9.

Garziera G, Morsch ALB, Otesbelgue F, Staub FL, Palominos PE, Brenol CV, Silva DR. Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents. Clin Rheumatol. 2017;36(8):1891–1896.

Chung TT, Ko HJ, Lau CS, Chung HY. A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis. Rheumatol Int. 2020;(0123456789). https://doi.org/10.1007/s00296-020-04583-8

Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol. 2008;35(5):776–81.

Google Scholar 

Shimabuco AY, de Medeiros-Ribeiro AC, Miossi R, Bonfiglioli KR, de Moraes JCB, Gonçalves CR, et al. Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area. Clinics (Sao Paulo). 2020;75:e1870.

Article  Google Scholar 

Seong SS, Choi CB, Woo JH, Kang WB, Joung CL, Uhm WS, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol. 2007;34(4):706–11.

CAS  PubMed  Google Scholar 

Gómez-Reino JJ, Carmona L, Descalzo MÁ. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Care Res (Hoboken). 2007;57(5):756–61.

Article  Google Scholar 

Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38(9):1261–5. https://academic.oup.com/cid/article-lookup/doi/10.1086/383317.

Martins-Melo FR, Bezerra JMT, Barbosa DS, Carneiro M, Andrade KB, Ribeiro ALP, et al. The burden of tuberculosis and attributable risk factors in Brazil, 1990–2017: results from the global burden of Disease Study 2017. Popul Health Metr. 2020;18(Suppl 1):10.

Article  PubMed  PubMed Central